Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Revision to Enhance the Collection of Cervical Cancer Screening Data (U54)

The summary for the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Revision to Enhance the Collection of Cervical Cancer Screening Data (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Revision to Enhance the Collection of Cervical Cancer Screening Data (U54): This Funding Opportunity Announcement (FOA) invites revision applications from investigators with active PROSPR research center (U54) awards funded under RFA-CA-11-003 that are focused on screening for colorectal or breast cancers. This FOA solicits revision applications from these centers to expand the scope of their research activities to include screening for cervical cancer. The sole PROSPR center that is currently focused on cervical cancer is not eligible to apply for the revision award. The PROSPR Statistical Coordinating Center is also not eligible. Revision applications are expected to concentrate primarily on the collection of multilevel cervical cancer screening process data for submission to the PROSPR central data repository, but should also document expertise and capacity for participation in multicenter collaborative projects utilizing these data.
Federal Grant Title: Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Revision to Enhance the Collection of Cervical Cancer Screening Data (U54)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-14-001
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.393, 93.394, 93.399
CFDA Descriptions: Cancer Cause and Prevention Research; Cancer Detection and Diagnosis Research; Cancer Control
Current Application Deadline: Jan 13, 2014
Original Application Deadline: Jan 13, 2014
Posted Date: Nov 4, 2013
Creation Date: Nov 4, 2013
Archive Date: Feb 13, 2014
Total Program Funding:
Maximum Federal Grant Award: $650,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-14-001.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com